Cargando…
Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis
OBJECTIVES: Existing findings regarding the relationship between comorbidities and the severity of coronavirus disease 2019 (COVID-19) are inconsistent and insufficient. The aim of this study was to evaluate the association between different comorbidities and the severity of COVID-19. METHODS: The P...
Autores principales: | Zhou, Yue, Yang, Qing, Chi, Jingwei, Dong, Bingzi, Lv, Wenshan, Shen, Liyan, Wang, Yangang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381888/ https://www.ncbi.nlm.nih.gov/pubmed/32721533 http://dx.doi.org/10.1016/j.ijid.2020.07.029 |
Ejemplares similares
-
Impaired glucose tolerance is associated with enhanced postprandial pancreatic polypeptide secretion
por: Zhao, Yanyun, et al.
Publicado: (2022) -
Comorbidities and severity of coronavirus disease 2019 patients
por: Radwan, Nashwa M., et al.
Publicado: (2020) -
Effects of sodium–glucose cotransporter 2 inhibitors on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
por: Xing, Baodi, et al.
Publicado: (2020) -
LncRNA ZFAS1 regulates the proliferation, oxidative stress, fibrosis, and inflammation of high glucose-induced human mesangial cells via the miR-588/ROCK1 axis
por: Geng, Zhuang, et al.
Publicado: (2022) -
Hyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications
por: Si, Ke, et al.
Publicado: (2021)